Mini reviewOpen Access

Challenges and Perspectives of Omes & Omics in Assisted Reproductive Technologies: From Screening to Diagnostic

Volume 5 - Issue 4

**Moncef Benkhalifa*¹, Naima Belhadri¹, Stephanie Belloc², Rosalie Cabry¹, Hikmat Chahine³, Henri Copin¹, Pierre Miron⁴ and Timur Gurgan⁵**

Author Information Open or Close
- ¹ART & Reproductive Genetics and PERITOX Laboratory, Picardie University Jules Verne. Amiens. France
- ²Laboratoire Lavergne ACCOLAB, France
- ³Laboratoire FORTEBIO/UNILABS, France
- ⁴Centre d’aide médicale à la procréation FERTILYS. Laval, Canada
- ⁵ART & genetics. Gurgan Clinic Ankara and Bahcesehir University, Turkey
*Corresponding author: Moncef Benkhalifa, ART & Reproductive Genetics and PERITOX Laboratory. Regional University Hospital & School of Medicine. CURS. Picardie University Jules Verne. Amiens. France

Received: June 06, 2018; Published: June 14, 2018

DOI: 10.26717/BJSTR.2018.05.001229

Full Text PDF

To view the Full Article Peer-reviewed Article PDF

Abstract

In cellular physiology and functional biology, the suffix –ome refers to “all constituents considered together and as a mix”. During the last decade the omics development have significantly changed the face of fundamental and clinical biology for diagnostics and clinical treatment. By building bridges to cell biology, Omics technologies are no longer limited any more to research laboratories but started to be applied in clinical biology for prognostic and diagnostic [1]. For example, fast moving advances in next generation sequencing technologies makes human sequence datasets widely available and this represents a fundamental shift from basic research to clinical application. Genomics has already moved to the clinic and combining medical records with genome sequences offers tantalizing possibilities for the future of medicine [2]. IVF omes and omics are becoming promising technologies that personalize patient management and improve success rates [3,4].

Mini review| References|